Skip to Main Content

Author Details

Eric Lu
David Geffen School of Medicine at university of california los angeles
2017
19
8
PMIDPaper TitleJournal TitlePublished Year
36773955Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma.Urology2023
36481176Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Clin Genitourin Cancer2023
34724198Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.Cancer2022
35778337Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
36155169Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
34073773GO-Y078, a Curcumin Analog, Induces Both Apoptotic Pathways in Human Osteosarcoma Cells via Activation of JNK and p38 Signaling.Pharmaceuticals (Basel)2021
33558159The Evolving Landscape of Antibody-Drug Conjugates for Urothelial Carcinoma.Clin Genitourin Cancer2021
32424106Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.Proc Natl Acad Sci U S A2020
32043790Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.Oncologist2020
32727885Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2020
32565177New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma.Pharmacol Ther2020
30928160Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.Eur Urol2019
29388122Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.Ann Surg Oncol2018
30099369DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.J Natl Compr Canc Netw2018
30110670When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies.Am J Nephrol2018
30367302ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas.Ann Surg Oncol2018
29280473The Safety of Low-Molecular-Weight Heparin During and After Pregnancy.Obstet Gynecol Surv2017
28395768What constitutes an "unmet medical need" in oncology? An empirical evaluation of author usage in the biomedical literature.Semin Oncol2017
28450426Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors.Cancer Discov2017
  • 1 - 19 of 19

Recommended Authors

Mayo Clinic Arizona
Career Start Year 2015
Number of shared co-authors 0
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 7
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Center for Drug Evaluation and Research
Career Start Year 2007
Number of shared co-authors 1
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 9
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 6
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 0
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 2
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 3
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 17
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 2
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 10
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 3
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 7
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 5
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 2
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 3
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 2

Collaborators

University of California san francisco
Co-authored papers 5
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 5
University of California-San Francisco
Co-authored papers 5
UCSF Medical Center-Mount Zion
Co-authored papers 5
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
University of California Davis
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Co-authored papers 3
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Bluestar Genomics Inc.
Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
University of California los angeles
Co-authored papers 2
Invitae Corporation
Co-authored papers 2
University of California Davis Comprehensive Cancer Center
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California at Santa Cruz
Co-authored papers 2
Invitae Corporation
Co-authored papers 2
Invitae Corporation
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Invitae Corporation
Co-authored papers 2
University Hospital Center Sestre Milosrdnice
Co-authored papers 2
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 2
UF Health Cancer Center
Co-authored papers 2